AI-Powered Vaccine Shrinks Dog’s Cancer, Offers Hope for Personalized Medicine

In a remarkable case out of Australia, a tech entrepreneur utilized artificial intelligence tools – specifically ChatGPT and AlphaFold – to develop a personalized mRNA vaccine that significantly reduced the size of his dog’s cancerous tumor. This breakthrough offers a promising glimpse into the future of personalized cancer treatment for both animals and humans.

From Months to Live to a 75% Tumor Reduction

Paul Conyngham, a machine learning engineer in Sydney, adopted Rosie, a Staffordshire Bull Terrier-Shar Pei mix, in 2019. By 2024, Rosie was diagnosed with mast cell tumors on her leg. Traditional treatments like surgery, chemotherapy and immunotherapy provided limited relief, and veterinarians estimated she had only one to six months to live. 1 Determined to help his companion, Conyngham turned to AI.

How AI Helped Design the Vaccine

With no formal biomedical training, Conyngham leveraged his expertise in data analysis to formulate a plan. He consulted ChatGPT, which guided him toward genomic sequencing and vaccine design. The process involved several key steps:

• DNA Sequencing: Rosie’s healthy DNA was compared to the tumor’s DNA to identify specific mutations. 3
• AlphaFold Analysis: Google DeepMind’s AlphaFold was used to predict the structures of the mutated proteins and identify potential drug targets. 1
• Vaccine Formulation: The AI-driven analysis generated a formula for an mRNA sequence, essentially a “recipe” for the vaccine. 1

A Collaborative Effort Brings the Vaccine to Life

Conyngham’s detailed analysis impressed scientists at the University of New South Wales (UNSW) Ramaciotti Centre for Genomics and the UNSW RNA Institute. Associate Professor Martin Smith at UNSW described Conyngham as “relentless” and was “gobsmacked” by his ability to identify relevant mutations despite having no background in biology. 1 The UNSW RNA Institute, led by Director Páll Thordarson, then synthesized the vaccine in under two months. 1

Remarkable Results and Future Implications

Rosie received her first injection of the experimental mRNA vaccine in December 2025. Within a month, the tumor, initially the size of a tennis ball, had shrunk by 75%. 1 Scientists emphasize that this is a single case and requires further controlled trials, but the results are nonetheless encouraging. 1

This case demonstrates the potential of AI to “democratize” drug design and accelerate the development of personalized cancer treatments. 1 The utilize of mRNA technology, already proven effective in COVID-19 vaccines, to target specific cancer proteins represents a significant advancement in modern medicine. 1

Key Takeaways

• AI tools like ChatGPT and AlphaFold can assist in the design of personalized cancer vaccines.
• Genomic sequencing and protein structure prediction are crucial steps in identifying cancer-specific targets.
• mRNA vaccine technology offers a promising avenue for personalized cancer treatment.
• This case highlights the potential for AI to accelerate drug discovery and development.

While Rosie’s story is unique, it provides a compelling proof of concept for the application of AI in oncology and offers hope for more effective and personalized cancer treatments in the future.